Advanced search
Publication Cover
Patient Preference and Adherence Volume 14, 2020 - Issue
Submit an article Journal homepage
178
Views
6
CrossRef citations to date
0
Altmetric
Review

Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review

Karin Luttropp1 ICON Clinical Research, Plc., Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0002-6278-1354
ORCID Icon,
Johan Dalén1 ICON Clinical Research, Plc., Stockholm, Sweden
,
Axel Svedbom1 ICON Clinical Research, Plc., Stockholm, Sweden
,
Mary Dozier2 ICON Clinical Research, Plc., Boston, MA, USA
,
Christopher M Black3 Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USAORCID Iconhttps://orcid.org/0000-0003-2934-108X
ORCID Icon &
Amy Puenpatom3 Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USACorrespondence[email protected]
Pages 309-320 | Published online: 17 Feb 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Knut Stavem. (2021) Switching from one reference biological to another in stable patients for non-medical reasons: a literature search and brief review. Journal of Market Access & Health Policy 9:1.
Read now

Articles from other publishers (5)

Anat Fisher, Jason D. Kim, Greg Carney & Colin Dormuth. (2022) Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia. BMC Rheumatology 6:1.
Crossref
Martina Tallarico, Caterina Palleria, Livia Ruffolo, Rocco Spagnuolo, Maria Diana Naturale, Adele Emanuela De Francesco, Caterina De Sarro, Rossella Romeo, Rita Citraro, Patrizia Doldo, Ludovico Abenavoli, Luca Gallelli, Francesco Luzza, Antonio Leo & Giovambattista De Sarro. (2022) Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study. Pharmaceutics 14:11, pages 2449.
Crossref
Derralynn A. Hughes, Patrick Deegan, Pilar Giraldo, Özlem Göker-Alpan, Heather Lau, Elena Lukina, Shoshana Revel-Vilk, Maurizio Scarpa, Jaco Botha, Noga Gadir & Ari Zimran. (2022) Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). Journal of Clinical Medicine 11:17, pages 5158.
Crossref
Kayoko Kaneko, Daniel Prieto-Alhambra, Clare Jacklin, Ailsa Bosworth, Sally Dickinson, Sarah Berry, Helen McAteer & Peter C Taylor. (2022) Influence of information provided prior to switching from Humira to biosimilar adalimumab on UK patients’ satisfaction: a cross-sectional survey by patient organisations. BMJ Open 12:2, pages e050949.
Crossref
Johan Dalén, Amy Puenpatom, Karin Luttropp, Axel Svedbom & Christopher M. Black. (2021) Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study. Advances in Therapy 39:1, pages 244-255.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.